1.78

3.49% 0.06

Tiziana Life Sciences Ltd (TLSA)

Overview News Price History Option Chain Discussions Forecast Stock Split

Tiziana Life Sciences Ltd stock is traded at $1.78, with a volume of 959.48K. It is up +3.49% in the last 24 hours and up +0.00% over the past month. Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

Previous Close:

$1.72

Open:

$1.71

24h Volume:

959.48K

Relative Volume:

2.89

Market Cap:

$211.51M

Revenue:

Net Income/Loss:

$-13.73M

P/E Ratio:

-13.69

EPS:

-0.13

Net Cash Flow:

$-3.92M

1W Performance:

+2.30%

1M Performance:

+0.00%

6M Performance:

+25.35%

1Y Performance:

+89.36%

1-Day Range:

$1.591

$1.80

1-Week Range:

$1.591

$1.82

52-Week Range:

$0.6295

$2.60

Tiziana Life Sciences Ltd Stock (TLSA) Company Profile

Name

Tiziana Life Sciences Ltd

Sector

Healthcare (1123)

Industry

Biotechnology (627)

Phone

Address

Employee

Twitter

@tizianals

Next Earnings Date

2024-05-27

Latest SEC Filings

TLSA's Discussions on Twitter

Compare TLSA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TLSA Tiziana Life Sciences Ltd	1.78	204.38M	0	-13.73M	-3.92M	-0.13
VRTX Vertex Pharmaceuticals Inc	452.04	113.14B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	741.29	78.49B	14.25B	4.58B	3.88B	41.77
ARGX Argen X Se Adr	877.94	54.76B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	397.55	54.51B	3.21B	43.57M	221.36M	0.2405
INSM Insmed Inc	197.01	41.64B	447.02M	-1.18B	-906.14M	-6.1812

Tiziana Life Sciences Ltd Stock (TLSA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-22-20	Initiated	B. Riley Securities	Buy
Dec-17-18	Initiated	Laidlaw	Buy

Tiziana Life Sciences Ltd Stock (TLSA) Latest News

Dec 13, 2025

TLSA Begins Enrollment for Phase 2 Alzheimer's Clinical Trial - GuruFocus

Dec 13, 2025

Tiziana Life Sciences (NASDAQ:TLSA) Trading Down 4.4%Here's Why - MarketBeat

Dec 13, 2025

Dec 12, 2025

Tiziana Life Sciences to Dose First Patient in Phase 2 Alzheimer’s Trial - Stock Titan

Dec 12, 2025

Tiziana Life Sciences to begin patient dosing in Phase 2 Alzheimer’s trial next week - Proactive financial news

Dec 12, 2025

Dec 11, 2025

Is Tiziana Life Sciences Ltd a good long term investmentLow Beta Stocks & Make Confident Moves With Forecasting Models - earlytimes.in

Dec 11, 2025

Dec 09, 2025

Tiziana Life Sciences Shares Drop After Company Unveils Plan to Spin Out IL-6 Program - MSN

Dec 09, 2025

Dec 05, 2025

Will Tiziana Life Sciences Ltd stock deliver shareholder valueInsider Buying & Daily Stock Trend Watchlist - Newser

Dec 05, 2025

Dec 04, 2025

How Tiziana Life Sciences Ltd stock reacts to job market data2025 Dividend Review & Stepwise Trade Execution Plans - Newser

Dec 04, 2025

Is Tiziana Life Sciences Ltd stock near bottom after declineJuly 2025 Selloffs & Precise Swing Trade Alerts - Newser

Dec 04, 2025

Will Tiziana Life Sciences Ltd stock attract ESG investorsWeekly Stock Recap & Low Risk Entry Point Guides - Newser

Dec 04, 2025

Dec 03, 2025